2009年，全球阿尔茨海默病的市场价值约为80亿美元，预计到2014年，其将增长到96亿美元，年复合增长率为3.7%。
最大的细分市场，2009年，缓和疾病疗法约为60亿美元，预计到2014年，其将增长到52亿美元，年复合增长率为-2.6%。
作为第二大细分市场， 2009年诊断/生物标记产值约为12亿美元，预计2014年，其将增长到29亿美元，年复合增长率为19.6%。
2009年，症状诊疗的市场产值为5.67亿美元，预计2014年，其将增长到7.26亿美元，年复合增长率为5.1%。
作为最小的细分市场，2009年，影像产品市场产值为3.61亿美元，预计到2014年，其将增长到8.52亿美元，年复合增长率为18.7%。
BCC旨在呈现目前一个完整的治疗和诊断技术情况，全面分析了市场，并列出在接下来几年里影响治疗领域的关键因素。
Global Market for Alzheimer’s Disease Therapeutics and Diagnostics to be Worth $9.6 Billion in 2014
Wellesley, Mass. – According to a new technical market research report, ALZHEIMER’S DISEASE THERAPEUTICS AND DIAGNOSTICS: GLOBAL MARKETS (PHM062A) from BCC Research (www.bccresearch.com), the value of the Alzheimer’s disease market is an estimated $8 billion in 2009, but is expected to increase to $9.6 billion in 2014, for a 5-year compound annual growth rate (CAGR) of 3.7%.
The largest segment of the market, disease-modifying therapeutics, is projected to decrease at a CAGR of -2.6%, dropping to $5.2 billion in 2014, after being valued at nearly $6 billion in 2009.
Diagnostics/biomarkers, the second-largest segment of the market, is estimated at $1.2 billion in 2009, and is expected to increase at a 5-year CAGR of 19.6% to reach nearly $2.9 billion in 2014.
The therapeutics for treatment of symptoms segment is expected to have a 5-year CAGR of 5.1%, with values of $567 million in 2009 and $726 million in 2014.
The smallest segment of the market, imaging products, is projected to have a healthy 5-year CAGR of 18.7%, rising from $361 million in 2009 to $852 million in 2014.
Alzheimer’s disease is becoming an increasingly difficult challenge to caregivers, families and the healthcare industry as the number of patients increases and the frustration with a lack of effective treatments grows. Though many marketed drugs have been approved for AD, this remains a significant area of unmet medical need. Clinical success has proven elusive; however, numerous companies are developing novel treatments.
BCC’s key objective was to present a comprehensive analysis of the current pipeline of therapeutic and diagnostic technologies, analyze the market, and outline key factors that will influence the therapeutic area in the next few years.
The intended audience for this report is the pharmaceutical and biotechnology industries and diagnostics, as well as the medical industry that treats patients in these areas.
更多相关研究：
阿兹海默病：新药?市场?企业研究报告——Alzheimer disease - new drugs, markets and companies
http://www.okokok.com.cn/Htmls/PE_Product/091112/59667.html
全球阿兹海默症治疗与诊断市场研究报告——Alzheimer's Disease Therapeutics and Diagnostics: Global Markets
http://www.okokok.com.cn/Htmls/PE_Product/100120/64547.html